ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 178 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $301,000 | -83.8% | 40,700 | -86.3% | 0.01% | -68.4% |
| Q4 2015 | $1,857,000 | -8.3% | 297,023 | -14.4% | 0.02% | -5.0% |
| Q3 2015 | $2,026,000 | -17.7% | 346,883 | +16.6% | 0.02% | -9.1% |
| Q2 2015 | $2,461,000 | -3.4% | 297,589 | -3.7% | 0.02% | -15.4% |
| Q1 2015 | $2,547,000 | -37.0% | 309,027 | -47.5% | 0.03% | +4.0% |
| Q4 2014 | $4,045,000 | +76.2% | 588,688 | +38.5% | 0.02% | +108.3% |
| Q3 2014 | $2,296,000 | +5.9% | 425,119 | +24.9% | 0.01% | +9.1% |
| Q2 2014 | $2,169,000 | -56.3% | 340,499 | -44.8% | 0.01% | -60.7% |
| Q1 2014 | $4,969,000 | +173.0% | 616,429 | +130.9% | 0.03% | +180.0% |
| Q4 2013 | $1,820,000 | -23.8% | 266,946 | +105.8% | 0.01% | -33.3% |
| Q3 2013 | $2,387,000 | +77.1% | 129,696 | +68.2% | 0.02% | +87.5% |
| Q2 2013 | $1,348,000 | – | 77,097 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |